MEEDER ASSET MANAGEMENT INC - CORVUS PHARMACEUTICALS INC ownership

CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 40 filers reported holding CORVUS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.

Quarter-by-quarter ownership
MEEDER ASSET MANAGEMENT INC ownership history of CORVUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$2,0000.0%1,984
+103.1%
0.00%
Q1 2022$2,000
-33.3%
977
+51.5%
0.00%
Q3 2021$3,000
+50.0%
6450.0%0.00%
Q2 2021$2,0000.0%6450.0%0.00%
Q1 2021$2,000
-33.3%
6450.0%0.00%
Q3 2020$3,000
+50.0%
645
+6.1%
0.00%
Q2 2020$2,000
+100.0%
6080.0%0.00%
Q1 2020$1,000
-90.9%
608
-70.9%
0.00%
-100.0%
Q4 2019$11,000
+57.1%
2,088
-6.0%
0.00%
Q3 2019$7,000
+75.0%
2,222
+120.9%
0.00%
Q2 2019$4,000
+300.0%
1,006
+241.0%
0.00%
Q1 2019$1,0000.0%295
-0.3%
0.00%
Q4 2018$1,000
-80.0%
296
-48.6%
0.00%
Q3 2018$5,000
+400.0%
576
+433.3%
0.00%
Q1 2018$1,0000.0%108
+10.2%
0.00%
Q4 2017$1,0000.0%98
+27.3%
0.00%
Q3 2017$1,000
-83.3%
77
-83.5%
0.00%
-100.0%
Q2 2017$6,000
+20.0%
466
+110.9%
0.00%
Q1 2017$5,0002210.00%
Other shareholders
CORVUS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
ADAMS STREET PARTNERS LLC 3,275,616$8,746,0001.82%
Telemetry Investments, L.L.C. 263,975$705,0000.97%
CHI Advisors LLC 719,132$1,920,0000.45%
BVF INC/IL 3,678,626$9,822,0000.37%
EcoR1 Capital, LLC 3,579,377$9,557,0000.36%
Orbimed Advisors 8,053,298$21,502,0000.22%
Stonepine Capital Management, LLC 46,886$125,0000.06%
Ikarian Capital, LLC 100,000$267,0000.02%
ALGERT GLOBAL LLC 19,737$53,0000.02%
Windsor Creek Advisors, LLC 14,786$39,0000.01%
View complete list of CORVUS PHARMACEUTICALS INC shareholders